Skip to content

AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients

Angiography-derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With ST-segment-elevation Myocardial Infarction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06947564
Enrollment
843
Registered
2025-04-27
Start date
2012-01-01
Completion date
2024-12-31
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Microvascular Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction

Keywords

AccuIMR, CMR, infarct size

Brief summary

In this study, we aimed to investigate the clinical significance of the angiography-based IMR calculation method (AccuIMR) and its prognostic assessment capability by evaluating the concordance or discordance between AccuIMR values and cardiac magnetic resonance (CMR) results.

Interventions

DIAGNOSTIC_TESTCMR

Coronary microvascular function was assessed using contrast-enhanced CMR after PCI.

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (1) STEMI patients who underwent PCI within 12 hours of symptom onset. * (2) coronary microvascular function was assessed using contrast-enhanced CMR after PCI.

Exclusion criteria

* (1) Suboptimal coronary angiographic images, including inadequate contrast opacification, unsatisfactory projection view, and severe overlap or distortion of the target vessel. * (2) Lacking two angiographic projections separated by at least 25° apart post-PCI. * (3) Inadequate CMR image quality

Design outcomes

Primary

MeasureTime frameDescription
CMRCMR was performed at a median of 5 days post-reperfusion.Contrast-enhanced CMR was performed on a 3.0-T scanner (Achieva TX, Philips Healthcare, Best, The Netherlands) . All sequences were acquired during breath-hold with a field of view at 350 × 350 mm2. Two experienced readers, blinded to clinical data, evaluated the CMR results using validated software (QMass MR 7.5, Medis, Leiden, The Netherlands). The acquired images were utilized to assess ventricular parameters and calculate the left ventricular ejection fraction (LVEF).

Secondary

MeasureTime frameDescription
LDL-C, mmol/LBlood samples were collected after a 12-hour fast in the second day post-PCI.Low-density cholesterol (LDL-C) is the cholesterol in low-density lipoprotein (LDL), which reflects how much LDL is present.
HbA1c, %Blood samples were collected after a 12-hour fast in the second day post-PCI.Hemoglobin a1c (HbA1c) is the combination of hemoglobin and blood sugar. Its concentration in the blood is stable and is not affected by short-term blood sugar concentrations. Hemoglobin A1C has obvious clinical value in the diagnosis of diabetes.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026